RNA
ligands of retinoic acid-inducible gene I (RIG-I) hold significant
promise as antiviral agents, vaccine adjuvants, and cancer immunotherapeutics,
but their efficacy is hindered by inefficient intracellular delivery
to the cytosol where RIG-I is localized. Here, we address this challenge
through the synthesis and evaluation of a library of polymeric carriers
rationally designed to promote the endosomal escape of 5′-triphosphate
RNA (3pRNA) RIG-I agonists. We synthesized a series of PEG-
block
-(DMAEMA-
co
-A
n
MA) polymers, where A
n
MA is an
alkyl methacrylate monomer ranging from
n
= 2–12
carbons, of variable composition, and examined effects of polymer
structure on the intracellular delivery of 3pRNA. Through
in vitro
screening of 30 polymers, we identified four lead
carriers (4–50, 6–40, 8–40, and 10–40,
where the first number refers to the alkyl chain length and the second
number refers to the percentage of hydrophobic monomer) that packaged
3pRNA into ∼100-nm-diameter particles and significantly enhanced
its immunostimulatory activity in multiple cell types. In doing so,
these studies also revealed an interplay between alkyl chain length
and monomer composition in balancing RNA loading, pH-responsive properties,
and endosomal escape, studies that establish new structure–activity
relationships for polymeric delivery of 3pRNA and other nucleic acid
therapeutics. Importantly, lead carriers enabled intravenous administration
of 3pRNA in mice, resulting in increased RIG-I activation as measured
by increased levels of IFN-α in serum and elevated expression
of
Ifnb1
and
Cxcl10
in major clearance
organs, effects that were dependent on polymer composition. Collectively,
these studies have yielded novel polymeric carriers designed and optimized
specifically to enhance the delivery and activity of 3pRNA with potential
to advance the clinical development of RIG-I agonists.